Indication

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

1 clinical trial

1 product

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Arm Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX, Followed by an Optional Open-Label Treatment With BOTOX, in Female Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Status: Active (not recruiting), Estimated PCD: 2024-07-05

Product